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SUMMARY 
  
This study aimed to observe the effects of Escherichia coli (Neocoliporvaccine – Merial) vaccination on diarrhoea percentages, 
growth parameters (average weight per piglet and average daily gain) and mortality rate in new-born piglets. A field trial was conducted 
in 35 litters of piglets from gilts selected from a farm in Perak. They were randomly allocated into Treatment (16 litters from E. coli 
vaccinated gilts) and Control (19 litters) groups respectively. Body weights of the piglets were measured at days 1, 7, 14 and 21 of age 
and the episodes of diarrhoea and piglet mortality were monitored daily for each pen. The Treatment group had significantly lower Day 1 
neonatal diarrhoea percentage (p < 0.05) and significantly lower mortality rate from Day 1 to Day 7. The total mortality rate for overall 
period of 1 - 21 days in the treatment group was at 3.90% when compared to the control group at 8.96%. However, there were no 
significant differences (p > 0.05)in the overall diarrhoea percentages (1 - 14 days) and weekly growth parameters between both groups. 
Environmental stress and inevitable routine treatment of diarrhoea with antimicrobials within the farm may have affected the significance 
of the diarrhoea percentages and growth parameters in this study. In conclusion, E. coli vaccination in gilts was shown to significantly 
reduce piglet mortality from Day 1 to Day 7 and neonatal diarrhoeal percentageson1-day-old piglets under typical farm conditions in this 
pilot study in Malaysia. 
  
Keywords: Escherichia coli vaccination, neonatal piglet diarrhoea percentage, neonatal piglet mortality rate, average weight per piglet, average daily 
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INTRODUCTION 
 
Escherichia coli, also known as E. coli, is an ubiquitous 
organism and one of the leading causes of diarrhoea in 
suckling piglets, especially in piglets reared under intensive 
management system (Fürer et al., 1982). Neonatal diarrhoea 
associated with E. coli is most commonly observed in 
piglets aged from 0 – 4 days (Loh et al., 2006; Schwartz, 
2009). The severity of neonatal diarrhoea associated with E. 
coli is also age-related, and the highest incidence of life-
threatening diarrhoea occurs during the first 2 to 5 days of 
life, with less serious diarrhoea occurring later (Loh et al., 
2006; Schwartz, 2009). Neonatal diarrhoea and deaths 
caused by enterotoxigenic Escherichia coli (ETEC) were 
observed in many herds, especially in piglets farrowed by 
gilts, whereas piglets from older sows showed lower 
vulnerability (Too, 1997; Riising et al., 2005).  
The high pre-weaning mortality rate in Malaysia of 
about 12% of total piglets born alive has not changed over a 
period of 15 years (1981–1996) and this post a major 
problem in the swine industry (Loh et al., 1999). Heavy 
losses have been reported in piglets during the first week of 
life in Malaysia and many were thought to be as a result of 
E. coli infection, or commonly known as colibacillosis, 
where more than 95% of E. coli isolated from diarrhoeic 
piglets had developed multiple antibiotic resistances, and 
more than 50% showed resistance to 10 types of 
antimicrobials tested (Loh et al. 2006) can impose a high 
economic impact to the producers.  
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Therefore, it is highly recommended to prevent this disease 
than to continuously fight it (Holden et al., 2006). 
Antibodies in colostrum provide passive protection to 
suckling piglets from sows that have built up immunity to 
specific E. coli strains (Carr, 2006). Active immunization of 
sows effectively provided protection to the newborn piglets 
through the transfer of antibodies via colostrum (Riising et 
al., 2005). The protection of newborn pigs against E. coli 
infection by sow vaccination has been a well-established 
practice in Denmark for more than 2 decades (Riising et al., 
2005). This practice is not commonly done in farm 
conditions in Malaysia. 
This study has its aim to observe the effects on the 
neonatal (first week) and pre-weaning (second and third 
week) performance of piglets sowed by gilts vaccinated 
with E. coli vaccine in a farm in Perak, Malaysia for the 
following parameters: (1) Diarrhoea percentages, (2) 
Growth Performance–average body weight and average 
daily gain and (3) Mortality rate. 
 
MATERIALS AND METHODS 
 
Study animals 
 
The field trial was carried out as a prospective study 
involving the progeny of 35 in-house bred Landrace-
Yorkshire gilts artificially inseminated with semen from in-
house bred Duroc boars, randomly assigned to Treatment 
Group – 16 gilts (vaccinated with E. coli bacterin – 
Treatment Group) and Control Group – 19 gilts, from a 
farm in Perak with a sow population of 4,000. Gilts were 
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placed into standard size farrowing pens in an intensive 
open house system and each litter of respective gilts 
consisting of siblings were monitored for 21 days. Cross 
fostering of piglets to other sows was strictly prohibited in 
this study. Good farm husbandry management and facilities 
(heating lamps) were equally provided to both groups. 
 
E. coli vaccine 
 
The vaccine tested is an inactivated vaccine 
(Neocolipor–Merial) containing recombinant porcine E. coli 
strains with F4 (F4ab, F4ac, F4ad), F5 adhesins and 
inactivated field porcine strain with F6, F41 adhesins. This 
covers the main adhesins that dominate in neonatal 
diarrhoea (Runnels et al., 1987). 
 
E. coli vaccination 
 
Vaccination of the treatment group was done prior to 
the study period. The first dose was given by 
intramuscular injection in the neck region behind the ear, 
5 – 7 weeks before farrowing, with the booster dose given 
2 weeks before farrowing. The newborn piglets were 
allowed to suckle colostrum. 
 
Evaluated Parameters 
 
The numbers of diarrhoeic piglets observed in each 
litter were recorded daily for 14 days. This was done by the 
visual observation of every piglet’s anus for stains of 
diarrhoea. Litter size and the cumulative weight of siblings 
were recorded on Days 1, 7, 14 and 21 using an analogue 
weighing scale, with an accuracy of 0.5kg. The average 
body weight and the average daily gain were computed. 
Piglets that died during the study were recorded as mortality 
throughout the 21 days of study. Although, the cause of 
death was not thoroughly investigated, piglets crushed by 
sow or died due to external trauma were excluded from the 
study. All data collected was analysed using Mann-
Whitney-U Test at 95% confidence level. 
 
RESULTS AND DISCUSSION 
 
Diarrhoea percentages 
 
The results for the average percentage of diarrhoea 
episodes per litter for Week 1 and 2 are shown in Figure 1. 
There were no statistical differences between groups (p > 
0.05), despite Treatment group exhibiting lower diarrhoea 
episodes in Week 1 and a non-significant slightly higher 
diarrhoea score in Week 2 compared to the Control group. 
These findings can be attributed partially to the higher 
mortality of piglets in the Control group in Week 1 (Figure 
1). Piglets with E. coli infection will most commonly suffer 
from severe neonatal secretory diarrhoea, leading to the 
death. Piglets that had died from the study were omitted, as 
no further data could be obtained from them after such 
point. These piglets may likely be the ones greatly affecting 
the diarrhoea scores, and subsequently the body weight 
parameters in the study. 
The average diarrhoea percentage per litter was further 
analysed on a daily basis for the first week (Figure 2). At 
day 1, control group piglets exhibited significantly more 
diarrhoea (p < 0.05) and had a higher peak percentage when 
compared to the piglets in the treatment group (i.e. 19.0% 
versus 13.8%, respectively). On day 2, peak diarrhoea 
episodes in both the treatment and control group piglets 
were observed.  
 
 
Figure 1: Average percentage of diarrhoea episodes per litter 
in Treatment and Control groups 
 
 
 
Figure 2: Average daily percentage of diarrhoea episode per 
litter during week 1 in Treatment and Control groups 
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The average percentages of diarrhoea per litter for the 
subsequent days were not significantly different (p > 0.05) 
and gradually declined in frequency in both groups. The 
peak in diarrhoea score at day-2 with subsequent declining 
pattern coincides with the manifestation of E. coli infection, 
when peak diarrhoea manifestation is usually between 2 to 5 
days of age (Schwartz, 2009). Other diseases causing 
neonatal diarrhoea were less likely, judging from the clinical 
signs and diarrhoeic patterns (Schwartz, 2009).  
 
Growth Performance 
 
The average body weight of the piglets from the Treatment 
and Control groups are shown in Figure 3. There were no 
significant differences in the average body weights of 
piglets (p > 0.05) in both Treatment and Control groups at 
all the ages monitored, i.e. day-1, day-7, day-14 and day-21, 
despite the higher body weights of 5.7% in the Treatment 
group over the Control group, i.e. 5.01kg and 4.74kg 
respectively at Day 21. 
 
 
 
Figure 3: Average body weight per piglet in Treatment and 
Control groups 
 
 
Figure 4: Average Daily Gain of the piglets in Treatment and 
Control groups 
 
The average daily gain (ADG) of the piglets from gilts 
vaccinated with E. coli bacterin vaccine and the control 
group are shown in Figure 4. Similar to the average body 
weight, the ADG of piglets in the Treatment group were 
higher than in the Control group, however the differences 
were not significant (p > 0.05). Piglets in the Treatment 
group had an overall better daily gain of 5.9% over piglets 
in the Control group from day 1 – 21. 
 
Mortality Rate 
 
The mortality rate observed for Treatment and Control 
groups at Weeks 1, 2 and 3 are shown in Table 1. Piglets in 
the Treatment group had a significantly lower mortality (p < 
0.05) during the first week as compared with the Control 
group (2.6% and 5.9%, respectively). It may be inferred that 
the piglets who were highly contributing to the diarrhoea 
score in Week 1 in the Control group did not survive to the 
second week, whereas, in the Treatment group, piglets 
having diarrhoea in Week 1 surviving into the second week 
were recorded for the incidence of diarrhoea. The surviving 
piglets from a diarrhoeic episode may perform slightly 
 
Table 1: The effects of E. coli vaccination on mortality rate in 
Treatment and Control groups 
 
Week Treatment (%) Control (%) 
1 2.60a 5.88b 
2 1.30 1.60 
 3 0 1.07 
Total Mortality Rate 3.90c 8.56d 
a, band c, d Values with different superscripts are significantly different  
(P <0.05) 
 
slower than normal healthy piglets (Edfors-Lilja et al., 
2000), subsequently affecting both the diarrhoea score and 
the growth parameters. There was no difference in piglet 
mortality in both groups during the second and third week 
of age. However, the mortality difference was significantly 
lower (p < 0.05) in the Treatment group as compared with 
the Control group for the overall period of 1 to 21 days (i.e. 
3.9% and 8.6%, respectively). Previous field trials carried 
out in Austria and Norway for the same E. coli vaccine 
showed piglet mortalities of 4% for the Treatment groups 
and 10% in the Control group, similar to the results in this 
study. This may suggest the reproducibility of the results 
under farm environments. 
Piglets in the Control group had consistently higher 
neonatal mortality rates when compared to the treatment 
group with a peak at days 3 and 4 (1.6%) at first week of 
age. The treatment group had peak mortalities at day 4 with 
a neonatal mortality rate of 1.3% (Table 2). 
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Table 2: Daily mortality rate of Treatment and Control group 
from Day 1 to Day 7 
 
Day Treatment (%) Control (%) 
1 
2 
3 
4 
5 
6 
7 
0 
0.65 
0.65 
1.30 
0 
0 
0 
0.53 
1.07 
1.61 
1.61 
0.53 
0.53 
0 
 
This study did not control for factors that include: (a) 
the unavailable data from diarrhoeic piglets that died in the 
first week of life, (b) other pathogens (other than E. coli) 
involved in neonatal diarrhoea and the diagnosis of the 
causes of diarrhoea and mortalities, (c) possible effects of 
the environment (cold weather during the study), 
management policies and other factors involved in a 
actively producing farm (blinded and equal treatment of 
diarrhoeic animals with sulphonamide-trimethoprim and 
gentamycin sulphate on both groups) to minimize 
production losses, and (d) dam effects (variable milk quality 
and quantity). 
 
CONCLUSION 
 
In conclusion, this pilot study showed significant 
reduction in the first week mortality of neonatal piglets and 
Day-one diarrhoeal percentages (p < 0.05) in piglets from 
gilts vaccinated with E. coli (Neocolipor – Merial) vaccine. 
The result is reproducible as it is in agreement with other 
field trials (Anon, 2003) which indicate that E. coli 
vaccination in dams could be an alternative way of 
moderating mortality due to E. coli in a farm environment. 
No significant differences (p > 0.05) were observed in the 
overall diarrhoeal percentages and growth parameters at the 
other ages monitored. These could be attributed to various 
factors, i.e.: (1) unavailable data after the mortalities of 
piglets, in particular from the Control group, (2) this study 
had no real control over external factors (ambient 
temperature, environmental stressors and routine farm 
practices such as giving treatment to the diarrhoeic piglets). 
More field trials and experimental studies are warranted to 
further investigate the effects of E. coli vaccination in gilts 
as well as on sows under natural and controlled 
environmental conditions to show its benefits on the control 
of piglet diarrhoea and subsequent performance of pigs in 
farm environments in Malaysia. 
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